PFE - Labcorp's companion diagnostic approved for use with Pfizer's hemophilia B gene therapy
2024-04-29 07:30:15 ET
Labcorp’s ( NYSE: LH ) assay has been cleared by the U.S. drug regulator for use with Pfizer's ( NYSE: PFE ) newly approved gene therapy to treat patients with hemophilia B....
Labcorp’s companion diagnostic approved for use with Pfizer’s hemophilia B gene therapy